Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children

被引:22
|
作者
Gentle, Samuel J.
Carlo, Waldemar A.
Tan, Sylvia
Gargano, Marissa
Ambalavanan, Namasivayam
Chawla, Sanjay
Bell, Edward F.
Bann, Carla M.
Hintz, Susan R.
Heyne, Roy J.
Tita, Alan
Higgins, Rosemary D.
机构
[1] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA
[2] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA
[3] Wayne State Univ, Childrens Hosp Michigan, Dept Pediat, Detroit, MI USA
[4] Wayne State Univ, Hutzel Womens Hosp, Detroit, MI USA
[5] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
[6] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA
[7] UT Southwestern, Dept Pediat, Dallas, TX USA
[8] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA
[9] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL USA
[10] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA
[11] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Rockville, MD USA
来源
OBSTETRICS AND GYNECOLOGY | 2020年 / 135卷 / 06期
基金
美国国家卫生研究院;
关键词
NECROTIZING ENTEROCOLITIS; INFANTS BORN; EXPOSURE; NEUROPROTECTION; BIRTH; MORTALITY;
D O I
10.1097/AOG.0000000000003882
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To test the primary hypothesis that extremely preterm children antenatally exposed to both magnesium sulfate and antenatal corticosteroids have a lower rate of severe neurodevelopmental impairment or death compared with those exposed to antenatal corticosteroids alone. METHODS: This was a prospective observational study of children born at 22 0/7-26 6/7 weeks of gestation from 2011 to 2014 atEunice Kennedy ShriverNational Institute of Child Health and Human Development Neonatal Research Network hospitals (N=3,093). The primary outcome was severe neurodevelopmental impairment or death at 18-26 months of corrected age follow-up based on exposure to antenatal corticosteroids and magnesium sulfate or antenatal corticosteroids alone. Secondary outcomes included components of severe neurodevelopmental impairment by exposure group and comparisons of severe neurodevelopmental impairment or death between children exposed to both antenatal corticosteroids and magnesium sulfate with those exposed to magnesium sulfate alone or to neither antenatal corticosteroids nor magnesium sulfate. Logistic regression models adjusted for background characteristics. RESULTS: Children exposed to both antenatal corticosteroids and magnesium sulfate had a lower rate of severe neurodevelopmental impairment or death (813/2,239, 36.3%) compared with those exposed to antenatal corticosteroids alone (225/508, 44.3%; adjusted odds ratio [aOR] 0.73; 95% CI 0.58-0.91), magnesium sulfate alone (47/89, 53%; aOR 0.49; 95% CI 0.29-0.82), or neither therapy (121/251; 48.2%; aOR 0.66, 95% CI 0.49-0.89). Similarly, children exposed to both antenatal corticosteroids and magnesium sulfate had a lower rate of death compared with either or neither therapy, but the rate of severe neurodevelopmental impairment among survivors did not differ between exposure groups. CONCLUSION: In children born between 22 0/7 and 26 6/7 weeks of gestation, exposure to both antenatal corticosteroids and magnesium sulfate was associated with lower rates of severe neurodevelopmental impairment or death and death compared with exposure to antenatal corticosteroids alone.
引用
收藏
页码:1377 / 1386
页数:10
相关论文
共 50 条
  • [21] Antenatal Neuroprotective Magnesium Sulfate in Very Preterm Infants and Its Association With Feeding Intolerance
    Bekmez, Buse Ozer
    Kutman, Hayriye Gozde Kanmaz
    Oguz, Yuksel
    Uygur, Dilek
    Elbayiyev, Sarkhan
    Canpolat, Fuat Emre
    Oguz, Serife Suna
    Tayman, Cuneyt
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 597 - 602
  • [22] Childhood neurodevelopmental outcome following extremely preterm birth
    Shankaran, Seetha
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (12): : 843 - 844
  • [23] Erythropoietin Improves Neurodevelopmental Outcome of Extremely Preterm Infants
    Neubauer, Achim-Peter
    Voss, Wolfgang
    Wachtendorf, Michael
    Jungmann, Tanja
    ANNALS OF NEUROLOGY, 2010, 67 (05) : 657 - 666
  • [24] Morphine exposure and neurodevelopmental outcome in extremely preterm infants
    Luzzati, Michele
    Coviello, Caterina
    Swarenburg-Veye, Henriette
    Dudink, Jeroen
    Dani, Carlo
    Koopmans, Corine
    deVries, Linda S.
    Groenendaal, Floris
    Benders, Manon
    Tataranno, Maria Luisa
    PEDIATRIC RESEARCH, 2021, 90 (SUPPL 1) : 8 - 8
  • [25] Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
    Trittmann, J. K.
    Nelin, L. D.
    Klebanoff, M. A.
    EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (09) : 1173 - 1180
  • [26] Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley, Fiona J.
    Crowther, Caroline
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (09): : 962 - 964
  • [27] Antenatal Exposure to Magnesium Sulfate and Neuroprotection in Preterm Infants
    Costantine, Maged M.
    Drever, Nathan
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2011, 38 (02) : 351 - +
  • [28] Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids
    Travers, Colm P.
    Carlo, Waldemar A.
    McDonald, Scott A.
    Das, Abhik
    Bell, Edward F.
    Ambalavanan, Namasivayam
    Jobe, Alan H.
    Goldberg, Ronald N.
    D'Angio, Carl T.
    Stoll, Barbara J.
    Shankaran, Seetha
    Laptook, Abbot R.
    Schmidt, Barbara
    Walsh, Michele C.
    Sanchez, Pablo J.
    Ball, M. Bethany
    Hale, Ellen C.
    Newman, Nancy S.
    Higgins, Rosemary D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : 130.e1 - 130.e13
  • [29] Prediction of Neurodevelopmental and Sensory Outcome at 5 Years in Norwegian Children Born Extremely Preterm
    Leversen, Katrine Tyborg
    Sommerfelt, Kristian
    Ronnestad, Arild
    Kaaresen, Per Ivar
    Farstad, Theresa
    Skranes, Janne
    Stoen, Ragnhild
    Elgen, Irene Bircow
    Rettedal, Siren
    Eide, Geir Egil
    Irgens, Lorentz M.
    Markestad, Trond
    PEDIATRICS, 2011, 127 (03) : E630 - E638
  • [30] Efficacy of Maternal Magnesium Sulfate Administration on the Neurodevelopmental Outcome of Preterm Babies: A Randomised Controlled Trial
    Sheeba, Lakshmi Mohanan
    Namboodiripad, Aparna
    Varanattu, Manoj C.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (12) : SC7 - SC9